⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11934544 | 1.00 | — | — | |
| SCHEMBL732693 | 1.00 | — | — | |
| SCHEMBL14021805 | 0.86 | — | — | |
| SCHEMBL14723791 | 0.85 | — | — | |
| SCHEMBL11937055 | 0.85 | — | — | |
| SCHEMBL11913589 | 0.84 | — | — | |
| SCHEMBL11934549 | 0.83 | — | — | |
| SCHEMBL403204 | 0.83 | — | — | |
| SCHEMBL10045290 | 0.83 | — | — | |
| SCHEMBL10357880 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9877961-B2 | Anticoagulant reversal agents | PEROSPHERE INC. (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170056396-A1 | ANTICOAGULANT REVERSAL AGENTS | PINWHEEL THERAPEUTICS INC. | 2017-03-02 | — | — | US | disclosed |
| US-20160361501-A1 | MULTIPLE DOSE PHARMACEUTICAL COMPOSITIONS CONTAINING HEPARIN AND/OR HEPARIN-LIKE COMPOUNDS AND DEVICES AND METHODS FOR DELIVERING THE SAME | VIRCHOW BIOTECH PVT. LTD. (IN) | 2016-12-15 | — | — | US | disclosed |
| US-20140336369-A1 | PROCESS FOR PREPARING HEPARINOIDS AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | APICORE US LLC (US) | 2014-11-13 | — | — | US | disclosed |
| US-20130005954-A1 | PROCESS FOR PREPARING HEPARINOIDS AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | APICORE, LLC | 2013-01-03 | — | — | US | disclosed |
| US-8209131-B2 | Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules | CURTIN UNIVERSITY OF TECHNOLOGY (AU) | 2012-06-26 | — | — | US | disclosed |